CHIMOVITS EREZ
CIK 1706399 · View on SEC EDGAR ↗
First SEC filing: Oct. 10, 2024 · Latest: June 11, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 7, 2026 | BRVE | P | 1,666,667 | $18.00 | $30,000,006 | 11,901,826 Indirect | +16.28% | Acquired | 53.7% (price as of 2026-08-21) |
| Aug. 7, 2026 | BRVE | P | 273,333 | $18.00 | $4,919,994 | 273,333 Indirect | — | Acquired | 53.7% (price as of 2026-08-21) |
| Oct. 15, 2024 | UPB | P | 660,000 | $17.00 | $11,220,000 | 4,554,873 Indirect | +16.95% | Acquired | -59.1% (price as of 2026-08-21) |
| Oct. 15, 2024 | UPB | P | 165,000 | $17.00 | $2,805,000 | 1,138,716 Indirect | +16.95% | Acquired | -59.1% (price as of 2026-08-21) |
| Jan. 14, 2020 | ELDN | S | 646,204 | $0.20 | $129,241 | 0 Indirect | — | Acquired | -0.8% (price as of 2026-08-21) |
| Jan. 14, 2020 | ELDN | S | 646,204 | $0.20 | $129,241 | 0 Indirect | — | Acquired | -0.8% (price as of 2026-08-21) |
| May 2, 2019 | ELDN | P | 646,204 | — | — | 646,204 Indirect | — | Acquired | (price as of 2026-08-21) |
| May 2, 2019 | ELDN | P | 646,204 | — | — | 646,204 Indirect | — | Acquired | (price as of 2026-08-21) |
| May 2, 2019 | ELDN | P | 646,204 | $3.10 | $2,003,232 | 3,183,314 Indirect | +25.47% | Acquired | -93.6% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 7, 2026 | BRVE | Series A Preferred Stock | Common Stock (9,132,420) | — | — | 40,000,000 | Disposed |
| Aug. 5, 2026 | BRVE | Stock Option (Right to Buy) | Common Stock (30,000) | $18.00 | Aug. 4, 2036 | 30,000 | Acquired |
| June 9, 2026 | UPB | Stock Option (Right to Buy) | Common Stock (17,096) | $6.69 | June 8, 2036 | 17,096 | Acquired |
| June 10, 2025 | UPB | Stock Option (Right to Buy) | Common Stock (17,096) | $11.59 | June 9, 2035 | 17,096 | Acquired |
| Oct. 15, 2024 | UPB | Series B redeemable convertible preferred stock | Common Stock (789,833) | — | — | 789,833 | Disposed |
| Oct. 15, 2024 | UPB | Series B redeemable convertible preferred stock | Common Stock (197,456) | — | — | 197,456 | Disposed |
| Oct. 15, 2024 | UPB | Series A redeemable convertible preferred stock | Common Stock (2,098,000) | — | — | 2,098,000 | Disposed |
| Oct. 15, 2024 | UPB | Series A redeemable convertible preferred stock | Common Stock (524,500) | — | — | 524,500 | Disposed |
| Oct. 10, 2024 | UPB | Stock Option (Right to Buy) | Common Stock (17,096) | $17.00 | Oct. 9, 2034 | 17,096 | Acquired |
| Sept. 17, 2020 | ACET | Stock Option (Right to Buy) | Common Stock (30,000) | $16.11 | Sept. 17, 2030 | 30,000 | Acquired |
| Jan. 14, 2020 | ELDN | Warrants to Purchase Common Stock | Common Stock (646,204) | — | May 2, 2024 | 646,204 | Acquired |
| Jan. 14, 2020 | ELDN | Warrants to Purchase Common Stock | Common Stock (646,204) | — | Nov. 2, 2020 | 646,204 | Acquired |
| July 11, 2019 | ELDN | Stock Option (Right to Buy) | Common Stock (20,000) | $0.88 | July 11, 2029 | 20,000 | Acquired |
| May 2, 2019 | ELDN | Warrants to Purchase Common Stock | Common Stock (646,204) | — | May 2, 2024 | 646,204 | Acquired |
| May 2, 2019 | ELDN | Warrants to Purchase Common Stock | Common Stock (646,204) | — | Nov. 2, 2020 | 646,204 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 10 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 5, 2026 | BRVE | Common Stock | 1,102,739 | Indirect |
| Aug. 5, 2026 | BRVE | Series A Preferred Stock→ Common Stock (9,132,420) | 9,132,420 | Indirect |
| Oct. 10, 2024 | UPB | Common Stock | 251,760 | Indirect |
| Oct. 10, 2024 | UPB | Common Stock | 1,007,040 | Indirect |
| Oct. 10, 2024 | UPB | Series A redeemable convertible preferred stock→ Common Stock (524,500) | 524,500 | Indirect |
| Oct. 10, 2024 | UPB | Series A redeemable convertible preferred stock→ Common Stock (2,098,000) | 2,098,000 | Indirect |
| Oct. 10, 2024 | UPB | Series B redeemable convertible preferred stock→ Common Stock (197,456) | 197,456 | Indirect |
| Oct. 10, 2024 | UPB | Series B redeemable convertible preferred stock→ Common Stock (789,833) | 789,833 | Indirect |
| Sept. 17, 2020 | ACET | No securities are beneficially owned | — | Indirect |
| May 11, 2017 | ELDN | Common Stock | 2,537,110 | Indirect |